Authors:
Bracken, MB
Aldrich, EF
Herr, DL
Hitchon, PW
Holford, TR
Marshall, LF
Nockels, RP
Pascale, V
Shepard, MJ
Sonntag, VKH
Winn, HR
Young, W
Citation: Mb. Bracken et al., Clinical measurement, statistical analysis, and risk-benefit: Controversies from trials of spinal injury, J TRAUMA, 48(3), 2000, pp. 558-561
Authors:
Smith, PR
Rosenberger, AH
Shepard, MJ
Wheeler, R
Citation: Pr. Smith et al., A P/M approach for the fabrication of an orthorhombic titanium aluminide for MMC applications, J MATER SCI, 35(13), 2000, pp. 3169-3179
Citation: Mj. Shepard et Mb. Bracken, Magnetic resonance imaging and neurological recovery in acute spinal cord injury: observations from the National Acute Spinal Cord Injury Study 3, SPINAL CORD, 37(12), 1999, pp. 833-837
Citation: Pr. Smith et al., Tape cast second generation orthorhombic-based titanium aluminide alloys for MMC applications, SCR MATER, 41(2), 1999, pp. 221-228
Authors:
Jackman, RJ
Nowels, KW
Rodriguez-Soto, J
Marzoni, FA
Finkelstein, SI
Shepard, MJ
Citation: Rj. Jackman et al., Stereotactic, automated, large-core needle biopsy of nonpalpable breast lesions: False-negative and histologic underestimation rates after long-term follow-up, RADIOLOGY, 210(3), 1999, pp. 799-805
Authors:
Bracken, MB
Shepard, MJ
Holford, TR
Leo-Summers, L
Aldrich, EF
Fazl, M
Fehlings, MG
Herr, DL
Hitchon, PW
Marshall, LF
Nockels, RP
Pascale, V
Perot, PL
Piepmeier, J
Sonntag, VKH
Wagner, F
Wilberger, JE
Winn, HR
Young, W
Citation: Mb. Bracken et al., Methylprednisolone or tirilazad mesylate administration after acute spinalcord injury: 1-year follow up - Results of the third National Acute SpinalCord Injury randomized controlled trial, J NEUROSURG, 89(5), 1998, pp. 699-706